Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02628067 |
|---|---|
| Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) |
| First Submitted : | December 9, 2015 |
| First Submitted that Met QC Criteria : | December 9, 2015 |
| First Posted : | December 11, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 7, 2022 |
| Last Update Posted : | June 8, 2022 |